Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis

被引:172
作者
Robinson, M
Regnis, JA
Bailey, DL
King, M
Bautovich, GJ
Bye, PT
机构
[1] ROYAL PRINCE ALFRED HOSP,RESP INVEST UNIT,CAMPERDOWN,NSW 2050,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,DEPT NUCL MED,SYDNEY,NSW,AUSTRALIA
[3] UNIV ALBERTA,PULM & CELL BIOL RES GRP,EDMONTON,AB,CANADA
关键词
D O I
10.1164/ajrccm.153.5.8630593
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In patients with cystic fibrosis (CF), dehydration of airway secretions leads to a decrease in mucociliary clearance (MCC). We examined the acute effect on MCC of a single administration by aerosolization of hypertonic saline (7%) (HS), amiloride (0.3% in 0.12% NaCl) (AML) and a combination of AML and HS (AM L + HS) in 12 patients with CF using a radioaerosol technique. Isotonic saline [0.9%] (IS) was used as a control solution. As both the AML and HS solutions induced cough in some patients, the last nine patients studied also underwent a cough clearance day. This was to eliminate the possible confounding effect of cough on MCC measurement. Patients ranged from 18 to 28 yr (mean +/- SD, 22 +/- 3) with an FEV(1) of 27 to 112% predicted (61 +/- 30%). Following deposition of the radioaerosol, baseline clearance was assessed for 30 min. This was followed by a 30-min intervention period. Assessment of post-intervention clearance for a further 30 min was then performed. Comparison of the amount of radioaerosol cleared from the right lung was made at 60 min (%C60) and 90 min (%C90) using repeated measures ANOVA. The percent cleared at 60 and 90 min was significantly increased with HS (%C60 = 26.5%, %C90 = 29.4%) and the combination of AML + HS (%C60 = 23.1%, %C90 = 27.4%) compared with both IS (%C60 = 14.7%, %C90 = 17.5%) and COUGH (%C60 = 18.0%, %C90 = 19.5%), p < 0.01. Inhalation of hypertonic saline is a potentially useful treatment in patients with cystic fibrosis.
引用
收藏
页码:1503 / 1509
页数:7
相关论文
共 33 条
  • [1] ALTMAN DG, 1992, PRACTICAL STAT MED R, P210
  • [2] ACUTE AND LONG-TERM AMILORIDE INHALATION IN CYSTIC-FIBROSIS LUNG-DISEASE - A RATIONAL APPROACH TO CYSTIC-FIBROSIS THERAPY
    APP, EM
    KING, M
    HELFESRIEDER, R
    KOHLER, D
    MATTHYS, H
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03): : 605 - 612
  • [3] STIMULATION OF PROSTAGLANDIN OUTPUT FROM RAT STOMACH BY HYPERTONIC SOLUTIONS
    ASSOULINE, G
    LEIBSON, V
    DANON, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 44 (03) : 271 - 273
  • [4] BAILEY DL, 1989, J NUCL MED, V30, P1865
  • [5] BOAT TF, 1994, AIRWAY SECRETION PHY, P217
  • [6] HUMAN AIRWAY ION-TRANSPORT .2.
    BOUCHER, RC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (02) : 581 - 593
  • [7] NA+ TRANSPORT IN CYSTIC-FIBROSIS RESPIRATORY EPITHELIA - ABNORMAL BASAL RATE AND RESPONSE TO ADENYLATE-CYCLASE ACTIVATION
    BOUCHER, RC
    STUTTS, MJ
    KNOWLES, MR
    CANTLEY, L
    GATZY, JT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) : 1245 - 1252
  • [8] PHYSICAL-PROPERTIES OF PURIFIED HUMAN RESPIRATORY MUCUS GLYCOPROTEINS - EFFECTS OF SODIUM-CHLORIDE CONCENTRATION ON THE AGGREGATION PROPERTIES AND SHAPE
    CHACE, KV
    NAZIRUDDIN, B
    DESAI, VC
    FLUX, M
    SACHDEV, GP
    [J]. EXPERIMENTAL LUNG RESEARCH, 1989, 15 (05) : 721 - 737
  • [9] CURTIS LN, 1984, AM REV RESPIR DIS, V129, P818
  • [10] KING M, 1972, AM CHEM SOC ORG COAT, V32, P327